Diana L Maas, MD | Medical College of Wisconsin

Diana L. Maas, MD

Associate Professor

view physician profile

Locations

Froedtert Hospital
Endocrinology - Froedtert Hospital

Specialties

Endocrinology

Languages

English

Secondary Appointments

Internal Medicine
Endocrinology, Diabetes and Metabolism

Contact Information

(414) 805-3666

Education

MD - Doctor of Medicine

Biography

I have been involved in the specialty of Endocrinology, Diabetes and Metabolism since the early 1990's. I received medical training, as well as completing my residency and fellowship here at the Medical College of Wisconsin and affiliated Hospitals, where I currently hold appointment as Associate Professor of Medicine, Endocrinology.

My clinical interests include pituitary tumors and other neuroendocrine disorders, adrenal, thyroid and parathyroid disorders, and thyroid cancer. I am particularly interested in pituitary disorders and I am the Director of the Pituitary Clinic. The neurosurgeons and I work as a team to take care of patients with pituitary tumors.

I am actively involved in a number of organizations, including The American Pituitary Society, American Association of Clinical Endocrinologists, and The Endocrine Society. I believe it is important to keep patients well informed about their medical problems and to educate them so they can be involved in their healthcare decisions.

Research Interests

As a fellow and researcher, I was mentored by Dr. Thad Hagen, a distinguished prolactin researcher who was also mentored by Dr. Ann Lawrence, a pioneer in prolactin research. I am no longer actively doing basic research, because I decided that my true passion was taking care of patients.

Highly divergent mussel lineages in isolated Indonesian marine lakes.

(Becking LE, de Leeuw CA, Knegt B, Maas DL, de Voogd NJ, Abdunnur, Suyatna I, Peijnenburg KT.) PeerJ. 2016;4:e2496.
My rings won't fit anymore. Ectopic growth hormone-secreting tumor.

(Chan MR, Ziebert M, Maas DL, Chan PS.) Am Fam Physician. 2005 May 01;71(9):1766-7.
Plasma leptin concentrations during extended fasting and graded glucose infusions: relationships with changes in glucose, insulin, and FFA.

(Sonnenberg GE, Krakower GR, Hoffmann RG, Maas DL, Hennes MM, Kissebah AH.) J Clin Endocrinol Metab. 2001 Oct;86(10):4895-900.
Relationships of plasma leptin levels to changes in plasma free fatty acids in women who are lean and women who are abdominally obese.

(Hennes MM, Dua A, Maas DL, Sonnenberg GE, Krakower GR, Kissebah AH.) Obes Res. 1997 Sep;5(5):442-6.
Leptin: a significant indicator of total body fat but not of visceral fat and insulin insensitivity in African-American women.

(Dua A, Hennes MI, Hoffmann RG, Maas DL, Krakower GR, Sonnenberg GE, Kissebah AH.) Diabetes. 1996 Nov;45(11):1635-7.
Reversible thioridazine-induced magnetic resonance imaging-documented pituitary enlargement associated with hyperprolactinemia.

(Maas DL, Hunt S, Mark L, Drobny EC.) Endocr Pract. 1996 Mar-Apr;2(2):85-9.
Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.

(Maas DL, Martinson DR, Erdmann MD, Wahle JS, Hagen TC.) Proc Soc Exp Biol Med. 1995 Nov;210(2):150-5.
Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.

(Maas DL, Meier DA, Wahle JS, Martinson DR, Hagen TC.) Mol Cell Neurosci. 1994 Apr;5(2):182-8.
Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.

(Maas DL, Arnaout MA, Martinson DR, Erdmann MD, Hagen TC.) Endocrinology. 1991 Feb;128(2):1015-20.